Evidence map›Paper›PMID 22133594›Full record

ArticleScience translational medicine2011

An NKG2D-mediated human lymphoid stress surveillance response with high interindividual variation.

Seema Shafi, Pierre Vantourout, Graham Wallace, Ayman Antoun, Robert Vaughan, Miles Stanford, Adrian Hayday

Abstract read
In one paragraph

Article in Science translational medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. L-type voltage-gated CaEMBO reports · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Genome-wide Study Identifies Association between HLA-BAmerican journal of human genetics · 2020
    Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Seema Shafi *Peter Gorer Department of Immunobiology, King's College London, UK.
Pierre Vantourout *Peter Gorer Department of Immunobiology, King's College London, UK.
Graham WallaceSchool of Immunity and Infection, University of Birmingham, UK.
Ayman AntounSchool of Cancer Studies, University of Birmingham, UK.
Robert VaughanClinical Transplantation Department, Guy's Hospital, London, UK.
Miles StanfordClinical Transplantation Department, Guy's Hospital, London, UK.
Adrian HaydayPeter Gorer Department of Immunobiology, King's College London, UK.
Cancer Research UK · GBSt Thomas' Hospital · GB

Funding

Cancer Research UKMedical Research CouncilWellcome Trust 085780
6 · The paper itself

Abstract

DNA damage or other physicochemical stresses may increase the expression of major histocompatibility complex class I-related stress antigens, which then activate lymphocytes. This lymphoid stress surveillance (LSS) not only can limit tumor formation but may also promote immunopathology. MICA is a highly polymorphic human stress antigen implicated in tumor surveillance, inflammation, and transplant rejection. However, LSS has not been conclusively demonstrated in humans, and the functional role for MICA polymorphisms remains to be established. We show that MICA coding sequence polymorphisms substantially affected RNA and protein expression. All donors tested showed LSS responses of γδ T and natural killer cells, but unexpectedly, each was individually "tuned." Hence, some responded optimally to highly expressed alleles, whereas others responded better to lower MICA expression, challenging the orthodoxy that higher stress antigen levels promote greater responsiveness. These individual variations in LSS tuning may help explain patient-specific differences in tumor immune surveillance, transplant rejection, and inflammation, as well as provide insight into immune evasion and immunosuppression.

Indexed as

Polymorphism, GeneticAnimalsCHO CellsCricetinaeCricetulusHistocompatibility Antigens Class IHumansImmunologic SurveillanceKiller Cells, NaturalLymphocyte ActivationNK Cell Lectin-Like Receptor Subfamily KStress, PhysiologicalT-LymphocytesHistocompatibility Antigens Class IKLRK1 protein, humanMHC class I-related chain ANK Cell Lectin-Like Receptor Subfamily K

Identifiers

PMID22133594
PMCPMC3966512
OpenAlexW2119354811

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.